Avantor Cost of Goods Sold 2018-2023 | AVTR

Avantor annual/quarterly cost of goods sold history and growth rate from 2018 to 2023. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Avantor cost of goods sold for the quarter ending December 31, 2023 was $1.152B, a 2.38% decline year-over-year.
  • Avantor cost of goods sold for the twelve months ending December 31, 2023 was $4.603B, a 6.24% decline year-over-year.
  • Avantor annual cost of goods sold for 2023 was $4.603B, a 6.24% decline from 2022.
  • Avantor annual cost of goods sold for 2022 was $4.91B, a 0.54% increase from 2021.
  • Avantor annual cost of goods sold for 2021 was $4.883B, a 13.22% increase from 2020.
Avantor Annual Cost of Goods Sold
(Millions of US $)
2023 $4,603
2022 $4,910
2021 $4,883
2020 $4,313
2019 $4,120
2018 $4,045
2017 $815
Avantor Quarterly Cost of Goods Sold
(Millions of US $)
2023-12-31 $1,152
2023-09-30 $1,142
2023-06-30 $1,154
2023-03-31 $1,156
2022-12-31 $1,181
2022-09-30 $1,206
2022-06-30 $1,263
2022-03-31 $1,261
2021-12-31 $1,260
2021-09-30 $1,218
2021-06-30 $1,232
2021-03-31 $1,173
2020-12-31 $1,209
2020-09-30 $1,099
2020-06-30 $988
2020-03-31 $1,017
2019-12-31 $1,044
2019-09-30 $1,030
2019-06-30 $1,041
2019-03-31 $1,005
2018-12-31
2018-09-30 $1,016
2018-06-30 $1,010
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $16.791B $6.967B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $122.475B 15.37
Cencora (COR) United States $44.674B 17.41
ICON (ICLR) Ireland $25.493B 24.07
DiDi Global (DIDIY) China $24.448B 0.00
Viatris (VTRS) United States $14.026B 4.03
CochLear (CHEOY) Australia $13.917B 0.00
Revvity (RVTY) United States $12.428B 21.78
Medpace Holdings (MEDP) United States $12.163B 40.02
Charles River Laboratories (CRL) United States $12.026B 21.92
Natera (NTRA) United States $11.711B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $11.540B 0.00
Solventum (SOLV) United States $11.153B 0.00
Sonic Healthcare (SKHHY) Australia $8.297B 0.00
HealthEquity (HQY) United States $6.740B 50.35
Organon (OGN) United States $5.043B 4.78
Bausch + Lomb (BLCO) Canada $4.779B 19.15
Doximity (DOCS) United States $4.494B 33.46
PACS (PACS) United States $3.725B 0.00
Sotera Health (SHC) United States $3.119B 15.31
Surgery Partners (SGRY) United States $3.118B 28.86
Progyny (PGNY) United States $3.049B 51.16
GoodRx Holdings (GDRX) United States $2.804B 142.00
Life Times (LTH) United States $2.783B 29.48
Premier (PINC) United States $2.460B 9.00
AMN Healthcare Services Inc (AMN) United States $2.256B 7.30
Teladoc Health (TDOC) United States $2.167B 0.00
Agilon Health (AGL) United States $1.985B 0.00
BrightSpring Health Services (BTSG) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.590B 0.00
Establishment Labs Holdings (ESTA) $1.451B 0.00
Agiliti (AGTI) United States $1.374B 22.44
Alignment Healthcare (ALHC) United States $1.264B 0.00
Pediatrix Medical (MD) United States $0.784B 8.11
Embecta (EMBC) United States $0.584B 3.86
InnovAge Holding (INNV) United States $0.549B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.528B 0.00
GeneDx Holdings (WGS) United States $0.512B 0.00
LifeMD (LFMD) United States $0.512B 0.00
Enhabit (EHAB) United States $0.511B 46.27
CareDx (CDNA) United States $0.503B 0.00
Auna S.A (AUNA) Luxembourg $0.480B 0.00
Sonida Senior Living (SNDA) United States $0.463B 0.00
MultiPlan (MPLN) United States $0.422B 0.00
Beauty Health (SKIN) United States $0.415B 0.00
ModivCare (MODV) United States $0.383B 7.18
DocGo (DCGO) United States $0.376B 60.17
Sera Prognostics (SERA) United States $0.352B 0.00
Sharecare (SHCR) United States $0.270B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.161B 0.00
So-Young (SY) China $0.128B 43.00
Oncology Institute (TOI) United States $0.080B 0.00
Pono Capital Two (PTWO) United States $0.075B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
NeueHealth (NEUE) United States $0.051B 0.00
Co-Diagnostics (CODX) United States $0.038B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
SeaStar Medical Holding (ICU) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
OncoCyte (OCX) United States $0.022B 0.00
DermTech (DMTK) United States $0.022B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
BIMI Holdings (BIMI) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
OpGen (OPGN) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.005B 0.00
Assure Holdings (IONM) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00